Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1

[1]  S. Teichmann,et al.  Local and systemic responses to SARS-CoV-2 infection in children and adults , 2021, Nature.

[2]  C. Conrad,et al.  Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children , 2021, Nature Biotechnology.

[3]  Guilin Wang,et al.  Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics , 2021, The Journal of experimental medicine.

[4]  P. Cresswell,et al.  Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein , 2021, Proceedings of the National Academy of Sciences.

[5]  I. Ulitsky,et al.  SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis , 2021, Nature.

[6]  Joaquin Lopez-Orozco,et al.  SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors , 2021, Journal of virology.

[7]  K. Herold,et al.  Natural mucosal barriers and COVID-19 in children , 2021, JCI insight.

[8]  Ruth R. Montgomery,et al.  Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes , 2021, PLoS biology.

[9]  Yu Chen,et al.  Coinfection with influenza A virus enhances SARS-CoV-2 infectivity , 2021, Cell Research.

[10]  M. Haniffa,et al.  Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2 , 2021, bioRxiv.

[11]  K. Herold,et al.  Natural Mucosal Barriers and COVID-19 in Children , 2021, medRxiv.

[12]  P. Vanhems,et al.  The incubation period of COVID-19: A meta-analysis , 2021, International Journal of Infectious Diseases.

[13]  S. Nisole,et al.  SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells , 2021, Journal of Virology.

[14]  C. Oldmeadow,et al.  ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma , 2021, Respirology.

[15]  H. Achdout,et al.  Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity , 2021, Nature Communications.

[16]  S. Chanda,et al.  MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells , 2020, Cell Reports.

[17]  A. Andiappan,et al.  Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles , 2020, PLoS pathogens.

[18]  J. Qiu,et al.  Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium , 2020, mBio.

[19]  M. Lipsitch,et al.  On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community , 2020, The Journal of infectious diseases.

[20]  A. Helenius,et al.  Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity , 2020, Science.

[21]  M. Moreli,et al.  Comparative epidemiology between the 2009 H1N1 influenza and COVID-19 pandemics , 2020, Journal of Infection and Public Health.

[22]  Steven M. Holland,et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.

[23]  Jacques Fellay,et al.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.

[24]  D. Meyerholz,et al.  Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract , 2020, EBioMedicine.

[25]  B. Muller-Pebody,et al.  Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design , 2020, medRxiv.

[26]  D. Cummings,et al.  Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries , 2020, medRxiv.

[27]  J. Borghi,et al.  Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes , 2020, Journal of medical virology.

[28]  Sijia He,et al.  A systematic review and meta‐analysis of children with coronavirus disease 2019 (COVID‐19) , 2020, Journal of medical virology.

[29]  L. Ren,et al.  Activation and evasion of type I interferon responses by SARS-CoV-2 , 2020, Nature Communications.

[30]  Vineet D. Menachery,et al.  Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures , 2020, Journal of Virology.

[31]  Nicolas Carlier,et al.  Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.

[32]  N. Ban,et al.  SARS-CoV-2 Nsp1 binds ribosomal mRNA channel to inhibit translation , 2020, bioRxiv.

[33]  D. Agard,et al.  A molecular pore spans the double membrane of the coronavirus replication organelle , 2020, Science.

[34]  D. Matthews,et al.  Neuropilin-1 is a host factor for SARS-CoV-2 infection , 2020, Science.

[35]  S. de Lusignan,et al.  COVID-19 in children: analysis of the first pandemic peak in England , 2020, Archives of Disease in Childhood.

[36]  Lisa E. Gralinski,et al.  SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract , 2020, Cell.

[37]  Q. Hamid,et al.  Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD , 2020, Molecular Therapy - Methods & Clinical Development.

[38]  Supinda Bunyavanich,et al.  Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. , 2020, JAMA.

[39]  Thomas Becker,et al.  Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 , 2020, Science.

[40]  Christopher Earl,et al.  Preexisting and de novo humoral immunity to SARS-CoV-2 in humans , 2020, Science.

[41]  Fang Li,et al.  Cell entry mechanisms of SARS-CoV-2 , 2020, Proceedings of the National Academy of Sciences.

[42]  R. Schwartz,et al.  Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.

[43]  Robert J. Mason,et al.  Pathogenesis of COVID-19 from a cell biologic perspective , 2020, European Respiratory Journal.

[44]  C. Gilks,et al.  A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  Yan Liu,et al.  Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.

[46]  G. Wong,et al.  SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.

[47]  Fabian J Theis,et al.  SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways , 2020, Nature Medicine.

[48]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[49]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[50]  Ba,et al.  Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults , 2020 .

[51]  J. Luban.  SARS-CoV-2 , 2020 .

[52]  E. Mendelson,et al.  Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1 , 2018, Viruses.

[53]  Yeonhee Ryu,et al.  Transmissibility and severity of influenza virus by subtype. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[54]  J. Parker,et al.  Age-Associated Changes in the Respiratory Epithelial Response to Influenza Infection , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[55]  A. Custovic,et al.  Pulmonary epithelial barrier and immunological functions at birth and in early life - key determinants of the development of asthma? A description of the protocol for the Breathing Together study , 2018, Wellcome open research.

[56]  新庄正宜.  インフルエンザワクチンとtest‐negative design , 2017 .

[57]  D. Chaussabel,et al.  Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency , 2015, Science.

[58]  Lewis D. Griffin,et al.  Automated Method for the Rapid and Precise Estimation of Adherent Cell Culture Characteristics from Phase Contrast Microscopy Images , 2013, Biotechnology and bioengineering.

[59]  J. Elborn,et al.  Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers , 2012, European Respiratory Journal.

[60]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[61]  L. Ostrowski,et al.  Interferon γ Stimulates Accumulation of Gas Phase Nitric Oxide in Differentiated Cultures of Normal and Cystic Fibrosis Airway Epithelial Cells , 2012, Lung.

[62]  M. Edwards,et al.  The Airway Epithelium: Soldier in the Fight against Respiratory Viruses , 2011, Clinical Microbiology Reviews.

[63]  Matthew Biggerstaff,et al.  Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  Kelly Bérubé,et al.  Human primary bronchial lung cell constructs: the new respiratory models. , 2010, Toxicology.

[65]  K. Pyrć,et al.  Human Coronavirus NL63 and 229E Seroconversion in Children , 2008, Journal of Clinical Microbiology.

[66]  F. Schmidt.  Meta-Analysis , 2008 .

[67]  P. Burgel,et al.  Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium , 2004, Thorax.

[68]  A. Monto,et al.  Acute respiratory illness in an American community. The Tecumseh study. , 1974, JAMA.

[69]  H J Montoye,et al.  The Tecumseh study. , 1970, Archives of environmental health.